Companies

Public Gene-Editing Companies

Gene-editing companies with listed shares, as held in the Atlas.

यह सूची कैसे बनती है

Companies in the Atlas that have shares traded on a public exchange. The Atlas does not carry share prices or market capitalisations — those change constantly, and a stale figure is worse than none.

#	प्रविष्टि	श्रेणी	स्थिति
1	CRISPR Therapeutics Co-founded by Emmanuelle Charpentier, and the company behind the first approved CRISPR…	CRISPR-Cas9 platform	Approved
2	Intellia Therapeutics Co-founded by Jennifer Doudna, and the company that first delivered CRISPR into a human…	In vivo CRISPR platform	Phase III
3	Beam Therapeutics Founded by David Liu and colleagues to commercialise base editing — precision changes to…	Base editing platform	Phase III
4	Editas Medicine One of the first CRISPR companies, which discontinued its cell-therapy and eye programmes…	In vivo editing	Preclinical
5	Prime Medicine Founded to commercialise prime editing, and the company behind the first published…	Prime editing platform	Phase I/II
6	Verve Therapeutics Built to turn heart disease into a one-time treatment, and acquired by Eli Lilly in 2025…	In vivo base editing	Phase II
7	Caribou Biosciences Co-founded by Jennifer Doudna, using hybrid RNA-DNA guides intended to make editing…	Cell therapy	Phase I
8	Sana Biotechnology Engineering transplanted cells to be invisible to the immune system, so they can be given…	Cell engineering	Phase I
9	Scribe Therapeutics Co-founded by Jennifer Doudna to engineer CRISPR enzymes from scratch rather than use the…	Engineered editors	Preclinical
10	Mammoth Biosciences Co-founded by Jennifer Doudna around ultra-compact CRISPR proteins small enough to fit…	Miniature editors and diagnostics	Preclinical
11	Arbor Biotechnologies Co-founded by Feng Zhang and David Scott to discover new editing enzymes from nature at…	Novel editors	Phase I
12	Vertex Pharmaceuticals The established biotechnology company that partnered on, and commercialises, the first…	Large biotechnology	Approved
13	bluebird bio A pioneer of lentiviral gene addition with several approved therapies — and a cautionary…	Gene addition	Approved
14	Tessera Therapeutics Developing 'gene writing' — mobile genetic elements repurposed to insert whole sequences…	Gene writing	Preclinical
15	Tune Therapeutics Turning genes up and down without changing sequence — epigenetic editing taken into early…	Epigenetic editing	Phase I
16	Sangamo Therapeutics The company that took gene editing into humans first, years before CRISPR existed as a…	Zinc finger platform	Phase III
17	Eli Lilly and Company A major pharmaceutical company that entered gene editing by acquisition, buying Verve…	Large pharmaceutical	Phase II

यह सूची आपको क्या नहीं बतातीEducational information only, not investment advice, and not a complete list of listed gene-editing companies. Nothing here is a recommendation regarding any security.

Written by The CRISPR Atlas editorial team Last updated Aug 25, 2026